Lucinactant

Lucinactant
Trade Name Surfaxin
Orphan Indication Bronchopulmonary dysplasia
USA Market Approval USA
USA Designation Date 2005-10-21 00:00:00
Sponsor Windtree Therapeutics, Inc.;2600 Kelly Road, Suite 100;Warrington, Pennsylvania, 18976